BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement f... (mailto:edagne@comstratgroup.comedagne@co...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent

Date:1/6/2009

=mailto:edagne@comstratgroup.com>edagne@comstratgroup.com

SOURCE BioMarin Pharmaceutical Inc.; La Jolla Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
2. BioMarin Provides Grant to NORD to Expand PKU Patient Support Services
3. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
4. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
5. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
6. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
7. BioMarin to Present at the Lehman Brothers Global Healthcare Conference
8. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
9. Pfizer Closes La Jolla Campus Due to Continuing Fire Emergency
10. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

Post Your Comments:

Breaking Medicine News(10 mins):Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10 Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11 Health News:Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment 2 Health News:Patriot Scientific Corporation Announces New Director 2 Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2 Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3

[0] NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus [0] Winner Medical Reports Fourth Quarter and Fiscal 2009 Results [0] Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment [0] Patriot Scientific Corporation Announces New Director [0] Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards

Other Medicine News:Health News:Merge Technologies Receives Expected Additional NASDAQ Notification 2 Health News:Merge Technologies Receives Expected Additional NASDAQ Notification 3 Health News:KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience 2 Health News:KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience 3 Health News:TraceSecurity Announces Partnership with PHNS Expanding Compliance Services to Hundreds of Healthcare Systems 2 Health News:TraceSecurity Announces Partnership with PHNS Expanding Compliance Services to Hundreds of Healthcare Systems 3 Health News:ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation 2 Health News:ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation 3 Health News:HealthPartners is National Benchmark in Six Out of Seven Areas in National Business Coalition on Health Report 2

Merge Technologies Receives Expected Additional NASDAQ Notification KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience JRRD releases single-topic issue on traumatic brain injury and polytrauma TraceSecurity Announces Partnership with PHNS Expanding Compliance Services to Hundreds of Healthcare Systems ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation HealthPartners is National Benchmark in Six Out of Seven Areas in National Business Coalition on Health Report

Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2 FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3 Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2 Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3 Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4 Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5 Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2 Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 57518 1 Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 57518 2 Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 1 Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 2 Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 3 Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 4 Alzheimers Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Propos 57510 1 Alzheimers Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Propos 57510 2 Alzheimers Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Propos 57510 3

[0] FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging [0] Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study [0] Hill-Rom Announces Appointment of James R. Giertz to Board of Directors

Other Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2 FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3 More Than 300 New Medicines Being Developed for Mental Illnesses 2 More Than 300 New Medicines Being Developed for Mental Illnesses 3 More Than 300 New Medicines Being Developed for Mental Illnesses 4

FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months More Than 300 New Medicines Being Developed for Mental Illnesses

Medicine Products:

Kappa 700 Pacing System AT500 Pacing System EnRhythm Pacing System GeneChip System 3000Dx